Comparing platforms for messenger RNA expression profiling of archival formalin-fixed, paraffin-embedded tissues

Journal of Molecular Diagnostics

Volumn 17, Issue 4, 2015, Pages 374-381

  Tyekucheva, Svitlana ^a,b   Martin, Neil E ^a   Stack, Edward C ^a,c   Wei, Wei ^d   Vathipadiekal, Vinod ^d   Waldron, Levi ^e   Fiorentino, Michelangelo ^f   Lis, Rosina T ^a,c   Stampfer, Meir J ^b,c   Loda, Massimo ^a,c,g,h   Parmigiani, Giovanni ^a,b   Mucci, Lorelei A ^b,c   Birrer, Michael ^d  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e City University of New York s Graduate School of Public Health Health Policy   (United States)

^f UNIVERSITY OF BOLOGNA   (Italy)

^g BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^h KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; BIOLOGICAL MARKER; MESSENGER RNA; PARAFFIN; TRANSCRIPTOME; FORMALDEHYDE; RNA;

ACCURACY; ADOLESCENT; ADULT; ARTICLE; CHILD; COMPARATIVE STUDY; FORMALIN TEST; GENE AMPLIFICATION; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; MALE; NUCLEOTIDE SEQUENCE; OVARY CANCER; OVARY CARCINOMA; PHASE 3 CLINICAL TRIAL (TOPIC); PRESCHOOL CHILD; PROSTATE; PROSTATECTOMY; REPRODUCIBILITY; TISSUE SECTION; CHEMISTRY; DNA MICROARRAY; FEMALE; GENETICS; OVARY TUMOR; PATHOLOGY; PROCEDURES; PROSPECTIVE STUDY; PROSTATE TUMOR; RANDOMIZED CONTROLLED TRIAL (TOPIC); TISSUE FIXATION;

CLINICAL TRIALS, PHASE III AS TOPIC; FEMALE; FORMALDEHYDE; GENE EXPRESSION PROFILING; HUMANS; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OVARIAN NEOPLASMS; PARAFFIN EMBEDDING; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RNA, MESSENGER; RNA, NEOPLASM; TISSUE FIXATION;

EID: 84931332029     PISSN: 15251578     EISSN: 19437811     Source Type: Journal    
DOI: 10.1016/j.jmoldx.2015.02.002     Document Type: Article

References (39)

1. R. Mirnezami, J. Nicholson, and A. Darzi Preparing for precision medicine N Engl J Med 366 2012 489 491
2. T.J. Lynch, D.W. Bell, R. Sordella, S. Gurubhagavatula, R.A. Okimoto, B.W. Brannigan, P.L. Harris, S.M. Haserlat, J.G. Supko, F.G. Haluska, D.N. Louis, D.C. Christiani, J. Settleman, and D.A. Haber Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib N Engl J Med 350 2004 2129 2139
3. D.J. Slamon, B. Leyland-Jones, S. Shak, H. Fuchs, V. Paton, A. Bajamonde, T. Fleming, W. Eiermann, J. Wolter, M. Pegram, J. Baselga, and L. Norton Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2 N Engl J Med 344 2001 783 792
4. S. Paik, S. Shak, G. Tang, C. Kim, J. Baker, M. Cronin, F.L. Baehner, M.G. Walker, D. Watson, T. Park, W. Hiller, E.R. Fisher, D.L. Wickerham, J. Bryant, and N. Wolmark A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer N Engl J Med 351 2004 2817 2826
5. Y. Hoshida, A. Villanueva, M. Kobayashi, J. Peix, D.Y. Chiang, A. Camargo, S. Gupta, J. Moore, M.J. Wrobel, J. Lerner, M. Reich, J.A. Chan, J.N. Glickman, K. Ikeda, M. Hashimoto, G. Watanabe, M.G. Daidone, S. Roayaie, M. Schwartz, S. Thung, H.B. Salvesen, S. Gabriel, V. Mazzaferro, J. Bruix, S.L. Friedman, H. Kumada, J.M. Llovet, and T.R. Golub Gene expression in fixed tissues and outcome in hepatocellular carcinoma N Engl J Med 359 2008 1995 2004
6. J. Cuzick, G.P. Swanson, G. Fisher, A.R. Brothman, D.M. Berney, J.E. Reid, D. Mesher, V. Speights, E. Stankiewicz, C.S. Foster, H. Møller, P. Scardino, J.D. Warren, J. Park, A. Younus, D.D. Flake, S. Wagner, A. Gutin, J.S. Lanchbury, S. Stone Transatlantic Prostate Group Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study Lancet Oncol 12 2011 245 255
7. S. von Ahlfen, A. Missel, K. Bendrat, and M. Schlumpberger Determinants of RNA quality from FFPE samples PLoS One 2 2007 e1261
8. L. Waldron, P. Simpson, G. Parmigiani, and C. Huttenhower Report on emerging technologies for translational bioinformatics: a symposium on gene expression profiling for archival tissues BMC Cancer 12 2012 124
9. K. Linton, Y. Hey, S. Dibben, C. Miller, A. Freemont, J. Radford, and S. Pepper Methods comparison for high-resolution transcriptional analysis of archival material on Affymetrix Plus 2.0 and Exon 1.0 microarrays Biotechniques 47 2009 587 596
10. M. Thomas, M. Poignee-Heger, M. Weisser, S. Wessner, and A. Belousov An optimized workflow for improved gene expression profiling for formalin-fixed, paraffin-embedded tumor samples J Clin Bioinforma 3 2013 10
11. P.P. Reis, L. Waldron, R.S. Goswami, W. Xu, Y. Xuan, B. Perez-Ordonez, P. Gullane, J. Irish, I. Jurisica, and S. Kamel-Reid mRNA transcript quantification in archival samples using multiplexed, color-coded probes BMC Biotechnol 11 2011 46
12. Final report on the aspirin component of the ongoing Physicians' Health Study. Steering Committee of the Physicians' Health Study Research Group N Engl J Med 321 1989 129 135
13. C.H. Hennekens, J.E. Buring, J.E. Manson, M. Stampfer, B. Rosner, N.R. Cook, C. Belanger, F. LaMotte, J.M. Gaziano, P.M. Ridker, W. Willett, and R. Peto Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease N Engl J Med 334 1996 1145 1149
14. R.A. Burger, M.F. Brady, M.A. Bookman, G.F. Fleming, B.J. Monk, H. Huang, R.S. Mannel, H.D. Homesley, J. Fowler, B.E. Greer, M. Boente, M.J. Birrer, S.X. Liang Gynecologic Oncology Group Incorporation of bevacizumab in the primary treatment of ovarian cancer N Engl J Med 365 2011 2473 2483
15. J.S. Hall, H.S. Leong, L.S. Armenoult, G.E. Newton, H.R. Valentine, J.J. Irlam, C. Moller-Levet, K.A. Sikand, S.D. Pepper, C.J. Miller, and C.M. West Exon-array profiling unlocks clinically and biologically relevant gene signatures from formalin-fixed paraffin-embedded tumour samples Br J Cancer 104 2011 971 981
16. R.D. Kennedy, M. Bylesjo, P. Kerr, T. Davison, J.M. Black, and E.W. Kay Development and independent validation of a prognostic assay for stage II colon cancer using formalin-fixed paraffin-embedded tissue J Clin Oncol 29 2011 4620 4626
17. D. Abdueva, M. Wing, B. Schaub, T. Triche, and E. Davicioni Quantitative expression profiling in formalin-fixed paraffin-embedded samples by affymetrix microarrays J Mol Diagn 12 2010 409 417
18. G.K. Geiss, R.E. Bumgarner, B. Birditt, T. Dahl, N. Dowidar, D.L. Dunaway, H.P. Fell, S. Ferree, R.D. George, T. Grogan, J.J. James, M. Maysuria, J.D. Mitton, P. Oliveri, J.L. Osborn, T. Peng, A.L. Ratcliffe, P.J. Webster, E.H. Davidson, L. Hood, and K. Dimitrov Direct multiplexed measurement of gene expression with color-coded probe pairs Nat Biotechnol 26 2008 317 325
19. R.A. Irizarry, B. Hobbs, F. Collin, Y.D. Beazer-Barclay, K.J. Antonellis, U. Scherf, and T.P. Speed Exploration, normalization, and summaries of high density oligonucleotide array probe level data Biostatistics 4 2003 249 264
20. R.A. Irizarry, B.M. Bolstad, F. Collin, L.M. Cope, B. Hobbs, and T.P. Speed Summaries of Affymetrix GeneChip probe level data Nucleic Acids Res 31 2003 e15
21. R.C. Gentleman, V.J. Carey, D.M. Bates, B. Bolstad, M. Dettling, S. Dudoit, B. Ellis, L. Gautier, Y. Ge, J. Gentry, K. Hornik, T. Hothorn, W. Huber, S. Iacus, R. Irizarry, F. Leisch, C. Li, M. Maechler, A.J. Rossini, G. Sawitzki, C. Smith, G. Smyth, L. Tierney, J.Y. Yang, and J. Zhang Bioconductor: open software development for computational biology and bioinformatics Genome Biol 5 2004 R80
22. F. Faul, E. Erdfelder, A.-G. Lang, and A. Buchner G∗Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences Behav Res Methods 39 2007 175 191
23. C.S. Grasso, Y.M. Wu, D.R. Robinson, X. Cao, S.M. Dhanasekaran, A.P. Khan, M.J. Quist, X. Jing, R.J. Lonigro, J.C. Brenner, I.A. Asangani, B. Ateeq, S.Y. Chun, J. Siddiqui, L. Sam, M. Anstett, R. Mehra, J.R. Prensner, N. Palanisamy, G.A. Ryslik, F. Vandin, B.J. Raphael, L.P. Kunju, D.R. Rhodes, K.J. Pienta, A.M. Chinnaiyan, and S.A. Tomlins The mutational landscape of lethal castration-resistant prostate cancer Nature 487 2012 239 243
24. J. Lapointe, C. Li, J.P. Higgins, M. van de Rijn, E. Bair, K. Montgomery, M. Ferrari, L. Egevad, W. Rayford, U. Bergerheim, P. Ekman, A.M. DeMarzo, R. Tibshirani, D. Botstein, P.O. Brown, J.D. Brooks, and J.R. Pollack Gene expression profiling identifies clinically relevant subtypes of prostate cancer Proc Natl Acad Sci U S A 101 2004 811 816
25. B.S. Taylor, N. Schultz, H. Hieronymus, A. Gopalan, Y. Xiao, B.S. Carver, V.K. Arora, P. Kaushik, E. Cerami, B. Reva, Y. Antipin, N. Mitsiades, T. Landers, I. Dolgalev, J.E. Major, M. Wilson, N.D. Socci, A.E. Lash, A. Heguy, J.A. Eastham, H.I. Scher, V.E. Reuter, P.T. Scardino, C. Sander, C.L. Sawyers, and W.L. Gerald Integrative genomic profiling of human prostate cancer Cancer Cell 18 2010 11 22
26. S.A. Tomlins, R. Mehra, D.R. Rhodes, X. Cao, L. Wang, S.M. Dhanasekaran, S. Kalyana-Sundaram, J.T. Wei, M.A. Rubin, K.J. Pienta, R.B. Shah, and A.M. Chinnaiyan Integrative molecular concept modeling of prostate cancer progression Nat Genet 39 2007 41 51
27. K.L. Penney, J.A. Sinnott, K. Fall, Y. Pawitan, Y. Hoshida, P. Kraft, J.R. Stark, M. Fiorentino, S. Perner, S. Finn, S. Calza, R. Flavin, M.L. Freedman, S. Setlur, H.D. Sesso, S.O. Andersson, N. Martin, P.W. Kantoff, J.E. Johansson, H.O. Adami, M.A. Rubin, M. Loda, T.R. Golub, O. Andren, M.J. Stampfer, and L.A. Mucci mRNA expression signature of Gleason grade predicts lethal prostate cancer J Clin Oncol 29 2011 2391 2396
28. A.C. Culhane, M.S. Schroder, R. Sultana, S.C. Picard, E.N. Martinelli, C. Kelly, B. Haibe-Kains, M. Kapushesky, A.A. St Pierre, W. Flahive, K.C. Picard, D. Gusenleitner, G. Papenhausen, N. O'Connor, M. Correll, and J. Quackenbush GeneSigDB: a manually curated database and resource for analysis of gene expression signatures Nucleic Acids Res 40 Database issue 2012 D1060 D1066
29. D.R. Schwartz, S.L. Kardia, K.A. Shedden, R. Kuick, G. Michailidis, J.M. Taylor, D.E. Misek, R. Wu, Y. Zhai, D.M. Darrah, H. Reed, L.H. Ellenson, T.J. Giordano, E.R. Fearon, S.M. Hanash, and K.R. Cho Gene expression in ovarian cancer reflects both morphology and biological behavior, distinguishing clear cell from other poor-prognosis ovarian carcinomas Cancer Res 62 2002 4722 4729
30. K.K. Zorn, T. Bonome, L. Gangi, G.V. Chandramouli, C.S. Awtrey, G.J. Gardner, J.C. Barrett, J. Boyd, and M.J. Birrer Gene expression profiles of serous, endometrioid, and clear cell subtypes of ovarian and endometrial cancer Clin Cancer Res 11 2005 6422 6430
31. M.P. Stany, V. Vathipadiekal, L. Ozbun, R.L. Stone, S.C. Mok, H. Xue, T. Kagami, Y. Wang, J.N. McAlpine, D. Bowtell, P.W. Gout, D.M. Miller, C.B. Gilks, D.G. Huntsman, S.L. Ellard, Y.Z. Wang, P. Vivas-Mejia, G. Lopez-Berestein, A.K. Sood, and M.J. Birrer Identification of novel therapeutic targets in microdissected clear cell ovarian cancers PLoS One 6 2011 e21121
32. N. Norton, Z. Sun, Y.W. Asmann, D.J. Serie, B.M. Necela, A. Bhagwate, J. Jen, B.W. Eckloff, K.R. Kalari, K.J. Thompson, J.M. Carr, J.M. Kachergus, X.J. Geiger, E.A. Perez, and E.A. Thompson Gene expression, single nucleotide variant and fusion transcript discovery in archival material from breast tumors PLoS One 8 2013 e81925
33. D. Wang, C. Wang, L. Zhang, H. Xiao, X. Shen, L. Ren, W. Zhao, G. Hong, Y. Zhang, J. Zhu, M. Zhang, D. Yang, W. Ma, and Z. Guo Evaluation of cDNA microarray data by multiple clones mapping to the same transcript OMICS 13 2009 493 499
34. P.A. Northcott, D.J. Shih, M. Remke, Y.J. Cho, M. Kool, C. Hawkins, C.G. Eberhart, A. Dubuc, T. Guettouche, Y. Cardentey, E. Bouffet, S.L. Pomeroy, M. Marra, D. Malkin, J.T. Rutka, A. Korshunov, S. Pfister, and M.D. Taylor Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples Acta Neuropathol 123 2012 615 626
35. L. Waldron, S. Ogino, Y. Hoshida, K. Shima, A.E. McCart Reed, P.T. Simpson, Y. Baba, K. Nosho, N. Segata, A.C. Vargas, M.C. Cummings, S.R. Lakhani, G.J. Kirkner, E. Giovannucci, J. Quackenbush, T.R. Golub, C.S. Fuchs, G. Parmigiani, and C. Huttenhower Expression profiling of archival tumors for long-term health studies Clin Cancer Res 18 2012 6136 6146
36. N. Erho, A. Crisan, I.A. Vergara, A.P. Mitra, M. Ghadessi, C. Buerki, E.J. Bergstralh, T. Kollmeyer, S. Fink, Z. Haddad, B. Zimmermann, T. Sierocinski, K.V. Ballman, T.J. Triche, P.C. Black, R.J. Karnes, G. Klee, E. Davicioni, and R.B. Jenkins Discovery and validation of a prostate cancer genomic classifier that predicts early metastasis following radical prostatectomy PLoS One 8 2013 e66855
37. S. Ward, A. Scope, R. Rafia, A. Pandor, S. Harnan, P. Evans, and L. Wyld Gene expression profiling and expanded immunohistochemistry tests to guide the use of adjuvant chemotherapy in breast cancer management: a systematic review and cost-effectiveness analysis Health Technol Assess 17 2013 1 302
38. C.A. Drukker, H. van Tinteren, M.K. Schmidt, E.J. Rutgers, R. Bernards, M.J. van de Vijver, and L.J. Van't Veer Long-term impact of the 70-gene signature on breast cancer outcome Breast Cancer Res Treat 143 2014 587 592
39. M. Doleshal, A.A. Magotra, B. Choudhury, B.D. Cannon, E. Labourier, and A.E. Szafranska Evaluation and validation of total RNA extraction methods for microRNA expression analyses in formalin-fixed, paraffin-embedded tissues J Mol Diagn 10 2008 203 211